Search hospitals > Ohio > Marietta
Marietta Memorial Hospital
Claim this profileMarietta, Ohio 45750
Global Leader in Parotid Gland Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Cervical Adenocarcinoma
Conducts research for Relapse
248 reported clinical trials
3 medical researchers
Summary
Marietta Memorial Hospital is a medical facility located in Marietta, Ohio. This center is recognized for care of Parotid Gland Cancer, Lung Cancer, Breast Cancer, Cervical Adenocarcinoma, Relapse and other specialties. Marietta Memorial Hospital is involved with conducting 248 clinical trials across 403 conditions. There are 3 research doctors associated with this hospital, such as Timothy D. Moore, Thomas Moore, MD, and John P. Kuebler.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage I
2Lung Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
Timothy D. MooreThe Mark H Zangmeister Center6 years of reported clinical research
Expert in Parotid Gland Cancer
Expert in Lung Cancer
126 reported clinical trials
208 drugs studied
Thomas Moore, MDDoctors Hospital8 years of reported clinical research
Studies Vulval Intraepithelial Neoplasia
Studies Ductal Carcinoma
1 reported clinical trial
2 drugs studied
John P. KueblerStrecker Cancer Center-Belpre13 years of reported clinical research
Studies Clear Cell Adenocarcinoma
Studies Breast Cancer
1 reported clinical trial
5 drugs studied
Clinical Trials running at Marietta Memorial Hospital
Breast Cancer
Lung Cancer
Cancer
Cutaneous Melanoma
Bladder Cancer
Bladder Carcinoma
Melanoma
Multiple Myeloma
Parotid Gland Cancer
Testicular cancer
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Cognitive Training
for Breast Cancer Survivors
This Phase III trial will examine the efficacy of computerized cognitive training methods on perceived cognitive impairment in breast cancer survivors.
Recruiting1 award N/A5 criteria
Marker-Directed Monitoring
for Breast Cancer
This trial studies if using blood tests to decide when to do scans is as effective as the standard way for monitoring patients with a specific type of breast cancer that has spread. The blood tests act like an early warning system for cancer activity.
Recruiting1 award N/A
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Marietta Memorial Hospital?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.